172 related articles for article (PubMed ID: 20529085)
1. Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus.
Kim WU; Min SY; Hwang SH; Yoo SA; Kim KJ; Cho CS
Clin Exp Immunol; 2010 Sep; 161(3):453-8. PubMed ID: 20529085
[TBL] [Abstract][Full Text] [Related]
2. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus.
Rider V; Jones S; Evans M; Bassiri H; Afsar Z; Abdou NI
J Rheumatol; 2001 Dec; 28(12):2644-9. PubMed ID: 11764210
[TBL] [Abstract][Full Text] [Related]
3. The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus.
Rastin M; Hatef MR; Tabasi N; Mahmoudi M
Clin Rheumatol; 2012 Mar; 31(3):417-24. PubMed ID: 21837431
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus.
Lee J; Shin EK; Lee SY; Her YM; Park MK; Kwok SK; Ju JH; Park KS; Kim HY; Cho ML; Park SH
Immunology; 2014 Aug; 142(4):573-80. PubMed ID: 24495300
[TBL] [Abstract][Full Text] [Related]
5. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
Feng Y
Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
[TBL] [Abstract][Full Text] [Related]
6. Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity.
Gorjestani S; Rider V; Kimler BF; Greenwell C; Abdou NI
Lupus; 2008 Jun; 17(6):548-54. PubMed ID: 18539708
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
Nagafuchi H; Wakisaka S; Takeba Y; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2002; 20(5):625-31. PubMed ID: 12412192
[TBL] [Abstract][Full Text] [Related]
10. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
11. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
Chen X; Wang LL; Cai B; Chen J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):588-90. PubMed ID: 16948902
[TBL] [Abstract][Full Text] [Related]
12. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
13. 17β-oestradiol enhances global DNA hypomethylation in CD4-positive T cells from female patients with lupus, through overexpression of oestrogen receptor-α-mediated downregulation of DNMT1.
Wu Z; Sun Y; Mei X; Zhang C; Pan W; Shi W
Clin Exp Dermatol; 2014 Jun; 39(4):525-32. PubMed ID: 24825143
[TBL] [Abstract][Full Text] [Related]
14. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
15. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
[TBL] [Abstract][Full Text] [Related]
16. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of Fas and Fas ligand on peripheral blood lymphocytes in normal subjects.
Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Koji T; Urayama S; Nakashima T; Kawabe Y; Nagataki S
J Lab Clin Med; 1998 Nov; 132(5):404-13. PubMed ID: 9823934
[TBL] [Abstract][Full Text] [Related]
18. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients.
Sunahori K; Nagpal K; Hedrich CM; Mizui M; Fitzgerald LM; Tsokos GC
J Biol Chem; 2013 Jul; 288(30):21936-44. PubMed ID: 23775084
[TBL] [Abstract][Full Text] [Related]
19. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
20. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
